Stockholders' Equity - Stock Options (Details) - Stock Options - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Stockholders' Equity | |||
| Stock options, Beginning balance | 127,000 | 27,000 | |
| Stock options, Granted | 100,000 | ||
| Stock options, Ending balance | 127,000 | 127,000 | 27,000 |
| Vested and exercisable as of June 30, 2024 | 120,250 | ||
| Weighted Average Exercise Price, Beginning balance | $ 8.88 | $ 31.35 | |
| Weighted Average Exercise Price, Granted | 2.81 | ||
| Weighted Average Exercise Price, Ending balance | 8.88 | $ 8.88 | $ 31.35 |
| Weighted Average Exercise Price, Vested and exercisable as of December 31, 2023 | $ 6.5 | ||
| Weighted Average Remaining Contractual Life, Outstanding (in years) | 7 years 7 months 6 days | 8 years 7 months 6 days | 6 years 5 months 8 days |
| Weighted Average Remaining Contractual Life, Vested and exercisable as of December 31, 2023 (in years) | 7 years 10 months 17 days | ||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|